Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - carbocisteine, promethazine hydrochloride - syrup - carbocisteine 2 g/100ml promethazine hydrochloride 0.05 g/100ml - antihistamines for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

karo pharma ab - pivmecillinam hydrochloride - film-coated tablet - 400 milligram(s) - penicillins with extended spectrum; pivmecillinam

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn. bhd. - pivmecillinam hydrochloride -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

equity pharmaceutical (pty) ltd - tablet - not indicated - none

Malta - English - Medicines Authority

sanofi malta limited - carbocisteine - syrup - carbocisteine 50 mg/ml - cough and cold preparations

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), tyrosine (unii: 42hk56048u) (tyrosine - unii:42hk56048u), arginine (unii: 94zla3w45f) (arginine - unii:94zla3w45f), proline (unii: 9dlq4ciu6v) (proline - unii:9dlq4ciu6v), alanine (unii: of5p57n2zx) (alanine - unii:of5p57n2zx), glutamic acid (unii: 3kx376gy7l) (glutamic acid - unii:3kx376gy7l), serine (unii: 452vly9402) (serine - unii:452vly9402), glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c), aspartic acid (unii: 30kyc7miai) (aspartic acid - unii:30kyc7miai), taurine (unii: 1eqv5mly3d) (taurine - unii:1eqv5mly3d), cysteine hydrochloride (unii: zt934n0x4w) (cysteine - unii:k848jz4886) - leucine 1.4 g in 100 ml - premasol 10% injection is indicated for the nutritional support of infants (including those of low birth weight) and young children requiring tpn via either central or peripheral infusion routes. parenteral nutrition with premasol 10% injection is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young children where: (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance (see dosage and administration). central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted infants, or those requiring long-term parenteral nutrition. for moderately catabolic or depleted patients in whom the central venous route is not indicated, diluted amino acid solutions mixed with 5-10% dextrose solutions may be infused by peripheral vein, supplemented, if desired, with fat emulsion. premasol 10% injection is contraindicated in patients with untreated anuria, hepatic coma, inborn errors of amino acid metabolism, including those involving branched chain amino acid metabolism such as maple syrup urine disease and isovaleric acidemia, or hypersensitivity to one or more amino acids present in the solution.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - isoleucine 0.9 g in 100 ml - hepatamine® is indicated for the treatment of hepatic encephalopathy in patients with cirrhosis or hepatitis. hepatamine® provides nutritional support for patients with these diseases of the liver who require parenteral nutrition and are intolerant of general purpose amino acid injections, which are contraindicated in patients with hepatic coma. hepatamine® is contraindicated in patients with anuria, inborn errors of amino acid metabolism, especially those involving branched chain amino acid metabolism such as maple syrup urine disease and isovaleric acidemia, or hypersensitivity to one or more amino acids present in the solution.

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - carbocisteine - syrup - carbocisteine 50 mg/ml - cough and cold preparations

Israel - English - Ministry of Health

mbi pharma ltd., israel - carglumic acid - dispersible tablets - carglumic acid 200 mg - carglumic acid - carglumic - acid waymade 200 mg is indicated for- hyperammonaemia due to n - acetylglutamate synthase primary deficiency. - hyperammonaemia due to isovaleric acidaemia. - hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

minimax medical pty ltd - 16187 - dental ceramic - this is a ceramic-based of material that is intended to be used in the mouth for dental restorative procedures such as the production of inlays, artificial teeth, metal-ceramic crowns, or bridges.